Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02927405

Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
State University of New York - Downstate Medical Center · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

There is an increasing trend on decreasing narcotic use and maximizing efficiency in the perioperative care. There are no studies that have compared a TAP block versus a TAP block plus gabapentin for laparoscopic procures.This study will investigate if taking gabapentin and receiving a TAP block decrease post-operative morphine consumption. It will be a randomized controlled, double blind study, with 130 patients between 18-60 years; that will undergo laparoscopic GYN procedures. Secondary outcomes will look at the incidence of nausea, vomiting, and VAS (verbal analog scale) scores. This combination may be helpful because gabapentin will be used to decrease visceral and central pain, and TAP block will decrease somatic pain. Performing a multimodal approach may decrease narcotic consumption, adverse effects and improve pain management.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinanticonvulsant drug that is used for neuropathic pain.
PROCEDURETAP Blocka procedure done anesthetize the anterior abdominal wall

Timeline

Start date
2020-03-04
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2016-10-07
Last updated
2021-05-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02927405. Inclusion in this directory is not an endorsement.